Nanomedicinal strategies as efficient therapeutic interventions for delivery of cancer vaccines.
The applications of gene therapy-based treatment of cancers were started almost two decades back as a boon over the chemotherapeutic treatment strategies. Gene therapy helps in correcting the genetic sequences for treatment of cancers, thus also acts like a vaccine to induce the cellular and humoral immunity. However, the cancer vaccines typically suffer from a series of biopharmaceutical challenges due to poor solubility, low systemic availability and lack of targeting ability. Owing to these challenges, the physicians and pharmaceutical scientists have explored the applications of nanocarriers as quite promising systems for effective treatment against the tumors. A series of nanotherapeutic systems are available to date for diverse drug therapy applications. Systematic understanding on the preparation, evaluation and application of nanomedicines as a carrier system for delivering the cancer vaccines is highly important. The present review article provides an in-depth understanding on the challenges associated with cancer vaccine delivery and current opportunities with diverse nanomedicinal carriers being available for treatment of cancers.
['Beg|Sarwar|S|', 'Kawish|S M|SM|', 'Panda|Sunil K|SK|', 'Tarique|Mohammed|M|', 'Malik|Arshi|A|', 'Afaq|Sarah|S|', 'Al-Samghan|Awad Saeed|AS|', 'Iqbal|Jawed|J|', 'Alam|Kainat|K|', 'Rahman|Mahfoozur|M|']
Nanomedicines Cancer Vaccines Drug targeting Immune response Nanoparticles